Fig. 1
From: Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?
Short review on the potential of cannabidiol on pathologic angiogenesis and endothelialitis. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the endothelial cells and led to pathologic angiogenesis and endothelial dysfunction. These features could be inhibited by using cannabidiol treatment. IL, interleukin; TNF-α, tumor necrosis factor α